Poseida Therapeutics to Present at BofA Securities 2022 Healthcare Conference
SAN DIEGO, April 28, 2022 /PRNewswire/ --Poseida Therapeutics, Inc. , Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced that the Company's Chief Executive Officer, Mark Gergen, will present at the BofA Securities 2022 Healthcare Conference on Tuesday, May 10, 2022 at 2:40pm PT in Las Vegas.
A live webcast of the presentation will be available on the Investors & Media Section of Poseida's website, www.poseida.com. A replay of the webcast will be available for approximately 30 days following the presentation.
About Poseida Therapeutics, Inc.
View original content to download multimedia:https://www.prnewswire.com/news-releases/poseida-therapeutics-to-present-at-bofa-securities-2022-healthcare-conference-301534768.html
SOURCE Poseida Therapeutics, Inc.
Company Codes: NASDAQ-NMS:PSTX